RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway

Jiao, YH; Li, YY; Zhang, JY; Zhang, S; Zha, YF; Wang, J

Zhang, S (通讯作者),Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Cardiol, 160 Pujian Rd, Shanghai 200127, Peoples R China.

BIOMOLECULES, 2022; 12 (2):

Abstract

Doxorubicin (DOX) is an effective chemotherapeutic agent that plays an unparalleled role in cancer treatment. However, its serious dose-dependent card......

Full Text Link